A Phase 2, Open-Label, Single-ArmStudy to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patientswith Relapsed or Refractory Hodgkin Lymphoma

Project: Research project

Project Details

Description

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma
StatusActive
Effective start/end date7/16/197/31/24

Funding

  • ADC THERAPEUTICS SA

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.